Transthyretin (TTR) amyloidosis is a disease that appears in three variants. One variant affects the elderly population with heart failure, the other two variants are hereditary and caused by an amino acid substitution in the gene, resulting in polyneuropathy and/or heart issues depending on the amino acid substitution. However, in all three variants, other organs may also be affected with amyloid deposition in the disease course. Amyloid fibrils of TTR (ATTR) contains a mixture of full-length protein and fragments (50-127). Luminescent conjugated oligothiophenes (LCO’s) are novel amyloid binding probes used to stain amyloid fibrils and these amyloid probes have the feature of characterizing the amyloid structure in terms of fluorescence spectra. Apart from LCO’s, a few other amyloid binding probes are used to stain recombinant amyloid transthyretin and native transthyretin for binding studies. The majority of generated TTR aggregates in vitro did not have the characteristic fluorescence spectra when bound to LCO’s and was observed as a clumped gel-like aggregate. The generation of recombinant TTR fibrils in vitro using the mutant TTR-T49M to obtain an aggregation prone fragment (50-127) after being treated with cyanogen bromide had a low yield of in vivo amyloid-like fibrils, but with characteristic LCO spectra. Carpal tunnel ATTR often precedes ATTR deposition in heart tissue. Amyloid transthyretin in carpal tunnel tissues was stained with LCO’s and used as a reference in the comparison against the in vitro generated recombinant amyloid transthyretin fibrils. This project also includes quantification of amyloid transthyretin in a few selected parts of the carpal tunnel tissue using ImageJ. In the long run this method could help in diagnosing TTR amyloidosis.

No description available.

In the face of global warming and shrinking resources of fossil fuels the interest in solar energy has increased in recent years. However, the low energy and cost efficiency of current solar cells has up to this date hindered solar energy from playing a major role on the energy market. Photon upconversion is the process in which light of low energy is converted to high energy photons. Lately, this phenomenon has attracted renewed interest and ongoing research in this field mainly focuses on solar energy applications, solar cells in particular. The aim of this study was to investigate and evaluate amyloid fibrils as nanotemplates for an upconversion system based on the dyes platinum octaetylporphyrin (PtOEP) and 9,10- diphenylanthracene (DPA). This well-known pair of organic dyes upconverts light in the visible spectrum through a mechanism known as sensitized triplet-triplet annihilation. Amyloid fibrils are β-sheet rich protein fibril structures, formed by self-assembly of peptides. Amyloid fibrils were prepared from whey protein isolate using heat and acidic solutions. Dyes were incorporated according to a wellestablished technique, in which dyes are grinded together with the protein in solid state prior to fibrillization. Photophysical properties of pure fibrils and dye-incorporated fibrils were studied using UV-VIS spectroscopy and fluorescence spectroscopy. Atomic force microscopy was further employed to confirm the presence of amyloid fibrils as well as to study fibril structure. Results indicate that amyloid fibrils may not be the optimal host material for the upconversion system PtOEP/DPA. It was found that the absorption and emission spectra of this system overlap to a great deal with that of the fibrils. Though no upconverted emission clearly generated by the dye system was recorded, anti-Stokes emission was indeed observed. Interestingly, this emission appears to be strongly enhanced by the presence of dyes. It is suggested that this emission may be attributed to the protein residues rather than the amyloid structure. Future studies are encouraged to further investigate these remarkable findings. / Intresset för solceller har ökat under de senaste åren, till stor del tillföljd av den globala uppvärmningen och de sinande oljeresurserna. Dagens solceller har dock problem med låg energi- och kostnadseffektivitet, vilket gör att solenergin än så länge har svårt att hävda sig på energimarknaden. Photon upconversion är ett fotofysikaliskt fenomen där fotoner med låg energi omvandlas till fotoner med hög energi. Den senaste tiden har denna process fått förnyat intresse och forskningen inom området har ökat, inte minst med sikte på att integrera processen i solceller och därmed öka dess effektivitet. Målet med denna studie var att undersöka huruvida amyloidfibriller kan användas som stomme för ett photon upconversion-system baserat på platinum-oktaetylporfyrin (PtOEP) och 9,10-difenylantracen (DPA). Dessa två organiska färgämnen är ett välkänt par som konverterar synligt ljus med låg frekvens till mer hög frekvent ljus i det synliga spektrumet, via en mekanism som kallas sensitized triplet-triplet annihilation. Amyloidfibriller är proteinbaserade fiberstrukturer med hög andel β-flak, vilka bildas genom självassociation av peptider. I denna studie skapades amyloidfibriller av vassleprotein genom upphettning i sur lösning. Färgämnena inkorporerades enligt en välbeprövad metod där proteinet mortlas tillsammans med färgämnena i fast tillstånd, innan fibrilleringsprocessen påbörjas. De fotofysikaliska egenskaperna hos fibriller med och utan färgämnen analyserade med UV-VIS samt fluorescensspektroskopi. Atomkraftsmikroskopi användes för att bekräfta att fibriller fanns i proven, samt för att studera dess struktur. De erhållna resultaten antyder att amyloidfibriller inte är ett optimalt material för systemet PtOEP/DPA, delvis på grund av att absorptions- och emissionsspektrumet för systemet överlappar med fibrillernas egna spektrum. Anti-Stokes emission detekterades, men denna är med stor sannolikhet inte orsakad av färgämnena. Dock noterades, intressant nog, att denna emission ökar betydligt i närvaro av färgämnena. En möjlighet är att denna emission är kopplad till monomerer i proteinet snarare än till fibrillstrukturen, eftersom emission observerades hos både nativt och fibrillerat protein. Framtida studier uppmuntras att vidare undersöka dessa effekter.

No / ß2-microglobulin (ß2m) forms amyloid fibrils that deposit in the musculo-skeletal system in patients undergoing long-term hemodialysis. How ß2m self-assembles in vivo is not understood, since the monomeric wild-type protein is incapable of forming fibrils in isolation in vitro at neutral pH, while elongation of fibril-seeds made from recombinant protein has only been achieved at low pH or at neutral pH in the presence of detergents or cosolvents. Here we describe a systematic study of the effect of 11 physiologically relevant factors on ß2m fibrillogenesis at pH 7.0 without denaturants. By comparing the results obtained for the wild-type protein with those of two variants (¿N6 and V37A), the role of protein stability in fibrillogenesis is explored. We show that ¿N6 forms low yields of amyloid-like fibrils at pH 7.0 in the absence of seeds, suggesting that this species could initiate fibrillogenesis in vivo. By contrast, high yields of amyloid-like fibrils are observed for all proteins when assembly is seeded with fibril-seeds formed from recombinant protein at pH 2.5 stabilized by the addition of heparin, serum amyloid P component (SAP), apolipoprotein E (apoE), uremic serum, or synovial fluid. The results suggest that the conditions within the synovium facilitate fibrillogenesis of ß2m and show that different physiological factors may act synergistically to promote fibril formation. By comparing the behavior of wild-type ß2m with that of ¿N6 and V37A, we show that the physiologically relevant factors enhance fibrillogenesis by stabilizing fibril-seeds, thereby allowing fibril extension by rare assembly competent species formed by local unfolding of native monomers.

No description available.

No description available.

La formation et le dépôt de fibres d'α-Synucléine dans le cerveau humain sont à l‟origine de la maladie de Parkinson. Cette thèse documente le rôle de deux chaperons moléculaires dans l‟assemblage en fibres de l'α-Syn : Hsc70 (protéine de choc thermique constitutivement exprimée chez l‟Homme) et Ssa1p (son équivalent chez la levure). Le but était d'élargir le catalogue d'effets connus des chaperons moléculaires sur α-Syn, pour éventuellement ouvrir la voie à des applications thérapeutiques. Nous avons montré que Hsc70 inhibe l'assemblage de l'α-Syn en fibres, en se liant avec une forte affinité à la forme soluble de l'α-Syn. Hsc70 se lie préférentiellement aux fibres de l'α-Syn, et cette liaison a un effet cytoprotecteur puisqu'elle rend les fibres moins toxiques pour les cellules de mammifères en culture. Pareillement à Hsc70, Ssa1p inhibe l'assemblage de l'α-Syn en fibres, et a une plus forte affinité pour les fibres que pour la forme soluble de l'α-Syn. En revanche, la liaison de Ssa1p aux fibres de l'α-Syn n'a pas d'effet cytoprotecteur, sûrement due aux différences entre les séquences du site de liaison aux peptides des deux chaperons moléculaires, qui fait que Ssa1p a une affinité plus faible que Hsc70 pour les fibres d'α-Syn. Nous avons fixé le complexe entre Ssa1p et α-Syn avec des agents pontants, pour ensuite établir une carte du site d'interaction entre les deux protéines en utilisant la spectrométrie de masse. Ceci est indispensable si un « mini » Ssa1p, constitué des éléments nécessaires et suffisants sera utilisé comme agent thérapeutique pour réduire la toxicité des fibres d'α-Syn. / The formation and deposition of α-Synuclein fibrils in the human brain is at the origin of Parkinson’s disease. The objective of my thesis was to document the role of two molecular chaperones on the assembly of α-Syn into fibrils: Hsc70, a constitutively expressed human heat shock protein, and Ssa1p, its yeast equivalent. The aim was to expand the catalogue of known effects of molecular chaperones on the PD implicated protein, which could have therapeutic significance. We showed that Hsc70 inhibits the assembly of α-Syn into fibrils, by binding with high affinity to the soluble form of α-Syn. We documented that Hsc70 binds preferentially to α-Syn fibrils and that this binding has a cytoprotective effect, as it renders the fibrils less toxic to cultured mammalian cells. Similarly to Hsc70, Ssa1p inhibits the assembly of α-Syn into fibrils, and has a higher affinity for fibrils than for the soluble form of α-Syn. On the other hand, binding of Ssa1p to α-Syn fibrils does not have a cytoprotective effect, almost certainly due to differences in the amino acid sequences of the peptide binding sites of the two molecular chaperones, which mean that Ssa1p has a lower affinity than Hsc70 for α-Syn fibrils. We stabilized the complex between Ssa1p and α-Syn using chemical cross-linkers, to then map the interaction site between the two proteins. This is indispensable if a “mini” Ssa1p, comprised of only what is necessary and sufficient of Ssa1p, is to be used as a therapeutic agent to decrease the toxicity of α-Syn fibrils. A therapeutic agent based on exogenous protein Ssa1p is less likely to trigger an autoimmune response than for example the endogenous protein Hsc70.

The sujet de cette these portait sur la caractérisation de la machinerie originale utilisée par les Mimiviridae pour glycosyler les fibrilles entourant leurs capsides en travaillant sur les prototypes des 3 lignées connues, Mimivirus (A), Megavirus chilensis (B) et Moumouvirus australensis (C). Les fibrilles de Mimivirus sont décorées par 2 polysaccharides différents :l’un est caractérisé par la répétition d’un disaccaride linéaire fait de 3)-α-L-Rha-(1→3)-β-D-GlcNAc-(1→, avec un pyruvate branché en position 4,6 du GlcNAc ; l’autre présente une unité répétée branchée de séquence 2)-α-L-Rha-(1→3)-β-D-GlcNAc-(1→ pour le squelette linéaire et du rhamnose branché en position 3 par de 2OMeVioNAc. Nous avons suggéré que les fibrilles de Megavirus sont décorées par plus d'une espèce de polysaccharides/oligosaccharides, donc l’un ayant présentant un trisaccharide de RhaNAc:α-L-4OMe-RhaNAc-(1→3)-α-L-RhaNAc-(1→3)-α-L-RhaNAc-(1→. Les fibrilles de Moumouvirus sont décorées de glucosamine, quinovosamine et bacillosamine. A partir de ces données expérimentales il devenait possible de rechercher de nouveaux gènes responsables de ces glycosylations spécifiques. Le cluster de 9 gènes déjà publié de Mimivirus a pu être étendu à 13 gènes. Un cluster de 14 gènes a été d’autre part identifié dans le génome de Moumouvirus, le premier cluster de gènes de la glycosylation identifié dans la lignée B. Parmi les gènes de glycosylation, l’analyse fonctionnelle in vitro de la protéine L142 a permis de démontrer qu’il s’agit d’une N-acétyltransferase. En conclusion, les fibrilles des Mimiviridae sont lourdement glycosylées and le type de sucres et leur organisation dépend de la lignée considérée. / The aim of this thesis is the study of the innovative glycosylation machinery used by the Mimiviridae family for the glycosylation of the fibrils sourrounding their capsid, using Mimivirus, Moumouvirus australensis and Megavirus chilensis as prototypes of lineages A, B and C, respectively. Mimivirus fibrils are decorated with two distinct polysaccharide: one is characterized by a linear disaccharide repeating unit made of 3)-α-L-Rha-(1→3)-α-D-GlcNAc-(1→, with a pyruvic acid branched at position 4,6 of GlcNAc.; the other has a branched repeating unit with the sequence 2)-α-L-Rha-(1→3)-β-D-GlcNAc-(1→ in the linear backbone and rhamnose further branched at position 3 by viosamine methylated at position 2 and acetylated at position 4. We suggested that Megavirus chiliensis fibrils are decorated by more than one polysaccharides/oligosaccharide species, one having this trisaccharide: α-L-4OMe-RhaNAc-(1→3)-α-L-RhaNAc-(1→3)-α-L-RhaNAc-(1→. Moumouvirus australensis fibrils are decorated with glucosamine and quinovosamine in addition to the rare sugar, bacillosamine. Starting from this experimental data, it was possible to identify new genes involved in glycosylation. As a result, the published nine-gene cluster of Mimivirus was extended to thirteen genes. A different cluster of fourteen genes was identified in Moumouvirus australensis, representing the first glycosylation gene cluster identified for the B lineage.Among the glycosylation genes, the function of L142 was investigated in vitro, demonstrating that it is an N-acetyltransferase. To conclude, the fibrils of Mimiviridae are heavily glycosylated and the type of sugars and their organization depends on their lineage.

The inherited form of primary open angle glaucoma, a disorder characterized by increased intraocular pressure and retina degeneration, is linked to mutations in the olfactomedin (OLF) domain of the myocilin gene. Disease-causing myocilin variants accumulate within trabecular meshwork cells instead of being secreted to the trabecular extracellular matrix thought to regulate aqueous humor flow and control intraocular pressure. Like other diseases of protein misfolding, we hypothesize myocilin toxicity originates from defects in protein biophysical properties. In this thesis, the first preparative recombinant high-yield expression and purification system for the C-terminal OLF domain of myocilin (myoc-OLF) is described. To determine the relative stability of wild-type (WT) and mutant OLF domains, a fluorescence thermal stability assay was adapted to provide the first direct evidence that mutated OLF is folded but less thermally stable than WT. In addition, mutant myocilin can be stabilized by chemical chaperones. Together, this work provides the first quantitative demonstration of compromised stability among identified OLF variants and placing myocilin glaucoma in the context of other complex diseases of protein misfolding. Subsequent investigations into the biophysical properties of WT myoc-OLF provide insight into its structure and function. In particular, myoc-OLF is stable in the presence of glycosaminoglycans (GAGs), as well as over a wide pH range in buffers with functional groups reminiscent of such GAGs. Myoc-OLF contains significant â-sheet and â-turn secondary structure as revealed by circular dichroism analysis. At neutral pH, thermal melts indicate a highly cooperative transition with a melting temperature of ~55°C. A compact core structural domain of OLF was identified by limited proteolysis and consists of approximately residues 238-461, which retains the single disulfide bond and is as stable as the full myoc-OLF construct. This construct also is capable of generating 3D crystals for structure determination. This data, presented in Chapter 3, inform new testable hypotheses for interactions with specific trabecular extracellular matrix components. To gain further insight into the biological function of myoc-OLF, a facile fluorescence chemical stability assay was designed to identify possible ligands and drug candidates. In the assay described in Chapter 4, the target protein is initially destabilized with a chemical denaturant and is tested for re-stabilization upon the addition of small molecules. The assay requires no prior knowledge of the structure and/or function of the target protein, and it is amendable to high-throughput screening. Application of the assay using a library of 1,280 compounds revealed 14 possible ligands and drug candidates for myoc-OLF that may also generate insights into myoc-OLF function. Due to the high â-sheet content of monomeric myoc-OLF and presence of an aggregated species upon myoc-OLF purification, the ability of myoc-OLF to form amyloid fibrils was suspected and verified. The fibril forming region was confirmed to reside in the OLF domain of myocilin. Kinetic analyses of fibril formation reveal a self-propagating process common to amyloid. The presence of an aggregated species was confirmed in cells transfected with WT myocilin, but to a greater extent in cells transfected with P370L mutant myocilin. Both cell lines stained positive for amyloid. Taken together, these results provide further insights into the structure of myocilin and suggest a new hypothesis for glaucoma pathogenesis. Finally, in a related study, small molecule drug candidates were investigated to treat acid â-glucosidase (GCase), the deficient lysosomal enzyme in Gaucher disease, another protein conformational disorder. Three new GCase active-site directed 3,4,5,6-tetrahydroxylazepane inhibitors were synthesized that exhibit half inhibitory concentrations (IC50) in the low millimolar to low micromolar range. Although the compounds thermally stabilize GCase at pH 7.4, only one of the synthesized analogs exhibits chaperoning activity under typical assay conditions. This successful pharmacological chaperone is also one in which GCase is in its proposed active conformation as revealed by X-ray crystallography. Probing the plasticity of the active-site of GCase offers additional insight into possible molecular determinants for an effective small molecule therapy for GD.

Les protéines amyloïdes sont impliquées dans les maladies neurodégénératives comme Alzheimer, Parkinson et les maladies à prions et forment des structures complexes, les fibres amyloïdes. Le mécanisme de formation de ces fibres est un processus complexe qui implique plusieurs espèces d’agrégats intermédiaires. Parmi ces espèces, des petits agrégats, les oligomères, sont reconnus comme étant l’espèce amyloïde toxique, mais leur mécanisme de toxicité et d’agrégation sont mal compris. Cette thèse présente les résultats d’une étude numérique des premières étapes d’oligomérisation d’un peptide modèle GNNQQNY, issu d’une protéine prion, pour des systèmes allant du trimère au 50-mère, par le biais de simulations de dynamique moléculaire couplée au potentiel gros-grain OPEP. Nous trouvons que le mécanisme d’agrégation du peptide GNNQQNY suit un processus complexe de nucléation, tel qu’observé expérimentalement pour plusieurs protéines amyloïdes. Nous observons aussi que plusieurs chemins de formation sont accessibles à l’échelle du 20-mère et du 50-mère, ce qui confère aux structures un certain degré de polymorphisme et nous sommes capable de reproduire, dans nos simulations, des oligomères protofibrillaires qui présentent des caractéristiques structurelles observées expérimentalement chez les fibres amyloïdes. / Amyloid proteins are involved in neurodegenerative diseases such as Alzheimer’s, Parkinson’s and prion diseases and form complex structures called amyloid fibrils. The fibril formation mechanism is a complex process, which involves several intermediary species. Among these species, small early aggregates, called oligomers, are thought to be the toxic amyloid species but their toxicity and aggregation mechanisms are poorly understood. This thesis aims at presenting the results of a numerical study of the first oligomerization steps of the model peptide GNNQQNY, from a prion protein, for system sizes ranging from the trimer to the 50-mer, via molecular dynamics simulations using the OPEP coarse-grained potential. We find that GNNQQNY’s assembly follows a complex nucleation process, as observed experimentally for numerous amyloid proteins. We also observe that the 20-mer and 50-mer systems form polymorphic structures that are the byproducts of different formation pathways. We further report the spontaneous formation of protofibrillar oligomers with structural characteristics typical of experimentally determined amyloid fibril structures.